Interstitial continuous infusion therapy in a malignant glioma model in rats

Child's Nervous System

Volumn 25, Issue 6, 2009, Pages 655-662

  Tange, Yuichi ^a   Kondo, Akihide ^a,b   Egorin, Merrill J ^c   Mania Farnell, Barbara ^d   Daneriallis, Georgy M ^a   Nakazaki, Hiromichi ^a   Sredni, Simone T ^b   Rajaram, Veena ^a   Goldman, Stewart ^a   Soares, Marcelo B ^b   Tomita, Tadanori ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d PURDUE UNIVERSITY CALUMET   (United States)

Author keywords

Carboplatin; Chemotherapy; Convection enhanced delivery; Oxaliplatin; Rat model

Indexed keywords

CARBOPLATIN; OXALIPLATIN; PLATINUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG RETENTION; GLIOBLASTOMA; MALE; MAXIMUM TOLERATED DOSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CARBOPLATIN; CATHETERIZATION; CELL LINE, TUMOR; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLIOMA; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM TRANSPLANTATION; ORGANOPLATINUM COMPOUNDS; PLATINUM; RATS; RATS, INBRED F344; TREATMENT OUTCOME;

EID: 67349257409     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-008-0805-3     Document Type: Article

References (28)

1. JE Wolff T Trilling G Mölenkamp RM Egeler H Jürgens 1999 Chemosensitivity of glioma cells in vitro: a meta analysis J Cancer Res Clin Oncol 125 481 486 (Pubitemid 29410412)
2. MC Chamberlain 2006 Treatment options for glioblastoma Neurosurg Focus 20 E19
3. RA Kroll MA Pagel LL Muldoon S Roman-Goldstein SA Fiamengo EA Neuwelt 1998 Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers Neurosurgery 43 879 886 (Pubitemid 28436340)
4. DR Groothuis 2000 The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery Neuro Oncol 2 45 59
5. DJ Begley 2004 Delivery of therapeutic agents to the central nervous system: the problems and the possibilities Pharmacol Ther 104 29 45 (Pubitemid 39410561)
6. H Brem MS Mahaley Jr NA Vick KL Black SC Schold Jr PC Burger AH Friedman IS Ciric TW Eller JW Cozzens JN Kenealy 1991 Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas J Neurosurg 74 441 446
7. T Tomita 1991 Interstitial chemotherapy for brain tumors: review J Neurooncol 10 57 74
8. DM Lieberman DW Laske PF Morrison KS Bankiewicz EH Oldfield 1995 Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion J Neurosurg 82 1021 1029
9. MY Chen RR Lonser PF Morrison LS Governale EH Oldfield 1999 Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time J Neurosurg 90 315 320 (Pubitemid 29068134)
10. A Khan GI Jallo YJ Liu BS Carson Sr M Guarnieri 2005 Infusion rates and drug distribution in brain tumor models in rats J Neurosurg 102 Suppl. 53 58
11. JW Degen S Walbridge AO Vortmeyer EH Oldfield RR Lonser 2003 Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats J Neurosurg 99 893 898 (Pubitemid 37314926)
12. R Saito JR Bringas A Panner M Tamas RO Pieper MS Berger KS Bankiewicz 2004 Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model Cancer Res 64 6858 6862 (Pubitemid 39330991)
13. F Lévi G Metzger C Massari G Milano 2000 Oxaliplatin: pharmacokinetics and chronopharmacological aspects Clin Pharmacokinet 38 1 21 (Pubitemid 30055088)
14. E Jerremalm M Hedeland I Wallin U Bondesson H Ehrsson 2004 Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex Pharm Res 21 891 894 (Pubitemid 39011316)
15. E Rochard D Barthes P Courtois 1994 Stability and compatibility study of carboplatin with three portable infusion pump reservoirs Int J Pharm 101 257 262 (Pubitemid 24025160)
16. JS Kroin RD Penn 1982 Intracerebral chemotherapy: chronic microinfusion of cisplatin Neurosurgery 10 349 354
17. MJ Chang WD Yu LM Reyno RA Modzelewski MJ Egorin K Erkmen DR Vlock P Furmanski CS Johnson 1994 Potentiation by interleukin 1α of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model Cancer Res 54 5380 5386 (Pubitemid 2153672)
18. K Erkmen MJ Egorin LM Reyno R Morgan Jr JH Doroshow 1995 Effects of storage on the binding of carboplatin to plasma Cancer Chemother Pharmacol 35 254 256
19. NA Butowski PK Sneed SM Chang 2006 Diagnosis and treatment of recurrent high-grade astrocytoma J Clin Oncol 24 1273 1280 (Pubitemid 46622030)
20. ER Laws IF Parney W Huang F Anderson AM Morris A Asher KO Lillehei M Bernstein H Brem A Sloan MS Berger S Chang Glioma Outcomes Investigators 2003 Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project J Neurosurg 99 467 473 (Pubitemid 37040405)
21. S Sugiyama Y Yamashita T Kikuchi R Saito T Kumabe T Tominaga 2007 Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor J Neurooncol 82 41 47 (Pubitemid 46252271)
22. F Doz ME Berens DV Dougherty ML Rosenblum 1991 Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures J Neurooncol 11 27 35
23. PP Wang J Frazier H Brem 2002 Local drug delivery to the brain Adv Drug Deliv Rev 54 987 1013 (Pubitemid 35217752)
24. RS Kerbel BA Kamen 2004 The anti-angiogenic basis of metronomic chemotherapy Nat Rev Cancer 4 423 436 (Pubitemid 38745528)
25. W Chen DR Lu 1999 Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization J Microencapsul 16 551 563 (Pubitemid 29403553)
26. BS Carson Sr Q Wu B Tyler L Sukav R Raychaudhuri F DiMeco RE Clatterbuck A Olivi M Guarnieri 2002 New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery J Neurooncol 60 151 158 (Pubitemid 35291238)
27. C Friesen I Herr PH Krammer KM Debatin 1996 Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells Nat Med 2 574 577 (Pubitemid 26150685)
28. TH Finkel G Tudor-Williams NK Banda MF Cotton T Curiel C Monks TW Baba RM Ruprecht A Kupfer 1995 Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes Nat Med. 1 129 134